Yuichi Sato

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

Medicine, Pharmacology, Pharmacotherapy +15

A Novel Murine Model of Oral Candidiasis with Local Symptoms Characteristic of Oral Thrush

Natsuko Takakura, Yuichi Sato, Hiroko Ishibashi et al. · Microbiology and Immunology · 2003 · 159 citations · Full text

Dentistry, Oral Medicine, Medical Microbiology +16

Chemical Synthesis of Oligodeoxyribonucleotides Using <i>N</i>-Unprotected <i>H</i>-Phosphonate Monomers and Carbonium and Phosphonium Condensing Reagents:  <i>O</i>-Selective Phosphonylation and Condensation

Takeshi Wada, Yuichi Sato, Fumio Honda et al. · Journal of the American Chemical Society · 1997 · 99 citations

Pharmacy, Biochemistry, Chemistry +14

Overexpression of N-Acetylglucosaminyltransferase III Enhances the Epidermal Growth Factor-induced Phosphorylation of ERK in HeLaS3 Cells by Up-regulation of the Internalization Rate of the Receptors

Yuichi Sato, Motoko Takahashi, Yukinao Shibukawa et al. · Journal of Biological Chemistry · 2001 · 93 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16